Relevance of the immunohistochemical expression of cytokeratin 8/18 for the diagnosis and classification of breast cancer

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 4, 2008, Pages 479-483

  Cîmpean, Anca Maria ^a   Suciu, C ^a   Ceauşu, Raluca ^a   Tǎtucu, Diana ^a   Mureşan, Anca Maria ^a   Raica, M ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Breast tumors; Cytokeratin 8 18; Immunohistochemistry

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 8;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-18; KERATIN-8; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 70450065140     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. MOLL R., FRANKE W. W., SCHILLER D. L., GEIGER B., KREPLER R., The catalog of human cytokeratins: patterns ofexpression in normal epithelia, tumors and cultured cells, Cell, 1982, 31(1):11-24.
2. COULOMBE P. A., OMARY M. B., 'Hard' and 'soft' principles defining the structure, function and regulation ofkeratin intermediate filaments, Curr Opin Cell Biol, 2002, 14(1):110-122.
3. Rønnov-Jessen L., PETERSEN O. W., BISSEL M. J., Cellular changes involved in conversion of normal to malignantbreast: importance of the stromal reaction, Physiol Rev, 1996, 76(1):69-125.
4. Taylor-Papadimitrou J., STAMPFER M., BARTEK J., LEWIS A., BOSHELL M., LANE E. B., LEIGH I. M., Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium, J Cell Sci, 1989, 94(Pt 3):403-413.
5. PEROU C., SØRLIE T., EISEN M. B., VAN DE RIJN M., JEFFREY S. S., REES C. A., POLLACK J. R., ROSS D. T., JOHNSEN H., AKSLEN L. A., FLUGE O., PERGAMENSCHIKOV A., WILLIAMS C., ZHU S. X., LØNNING P. E., Børresen-Dale A. L., BROWN P. O., BOTSTEIN D., Molecular portraits of human breast tumours, Nature, 2000, 406(6797):747-752.
6. KORSCHING E., PACKEISEN J., AGELOPOULOS K., EISENACHER M., VOSS R., ISOLA J., VAN DIEST P. J., BRANDT B., BOECKER W., BUERGER H., Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis, Lab Invest, 2002, 82(11):1525-1533.
7. KNAPP A. C., FRANKE W. W., Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation, Cell, 1989, 59(1):67-79.
8. BLOUIN R., SWIERENGA S. H., MARCEAU N., Evidence for post-transcriptional regulation of cytokeratin geneexpression in a rat liver epithelial cell line, Biochem Cell Biol, 1992, 70(1):1-9.
9. CHOI I., GUDAS L. J., KATZENELLENBOGEN B. S., Regulation of keratin 19 gene expression by estrogen in humanbreast cancer cells and identification of the estrogen responsive gene region, Mol Cell Endocrinol, 2000, 164(1-2):225-237.
10. HESSE M., FRANZ T., TAMAI Y., TAKETO M. M., MAGIN T. M., Targeted deletion of keratins 18 and 19 leads to trophoblastfragility and early embryonic lethality, EMBO J, 2000, 19(9):5060-5070.
11. WOELFLE U., SAUTER G., SANTJER S., BRAKENHOFF R., PANTEL K., Down-regulated expression of cytokeratin 18promotes progression of human breast cancer, Clin Cancer Res, 2004, 10(8):2670-2674.
12. SCHALLER G., FUCHS I., PRITZE W., EBERT A., HERBST H., PANTEL K., WEITZEL H., LENGYEL E., Elevated keratin 18protein expression indicates a favorable prognosis in patients with breast cancer, Clin Cancer Res, 1996, 2(11):1879-1885.
13. BECKER M., NITSCHE A., NEUMANN C., AUMANN J., JUNGHAHN I., FICHTNER I., Sensitive PCR method forthe detection and real-time quantification of human cells in xenotransplantation systems, Br J Cancer, 2002, 87(11):1328-1335.
14. SOMMERS C. L., BYERS S. W., THOMPSON E. W., TORRI J. A., GELMANN E. P., Differentiation state and invasiveness ofhuman breast cancer cell lines, Breast Cancer Res Treat, 1994, 31(2-3):325-335.
15. SOMMERS C. L., HECKFORD S. E., SKERKER J. M., WORLAND P., TORRI J. A., THOMPSON E. W., BYERS S. W., GELMANN E. P., Loss of epithelial markers and acquisition of vimentin expression in adriamycin and vinblastine-resistant human breast cancer cell lines, Cancer Res, 1992, 52(19):5190-5197.
16. THOMPSON E. W., PAIK S., BRÜNNER N., SOMMERS C. L., ZUGMAIER G., CLARKE R., SHIMA T. B., TORRI J., DONAHUE S., LIPPMAN M. E., et al., Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines, J Cell Physiol, 1992, 150(3):534-544.
17. EGLAND K. A., VINCENT J. J., STRAUSBERG R., LEE B., PASTAN I., Discovery of the breast cancer gene BASE usinga molecular approach to enrich for genes encoding membrane and secreted proteins, Proc Natl Acad Sci USA, 2003, 100(3):1099-1104.
18. ZHANG R. D., FIDLER I. J., PRICE J. E., Relative malignant potential of human breast carcinoma cell lines establishedfrom pleural effusions and a brain metastasis, Invasion Metastasis, 1991, 11(4):204-215.
19. RUSSEL R. L., GEISINGER K. R., MEHTA R. R., WHITE W. L., SHELTON B., KUTE T. E., nm23-relationship to the metastaticpotential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients, Cancer, 1997, 79(6):1158-1165.
20. BÜHLER H., SCHALLER G., Transfection of keratin 18 gene in human breast cancer cells causes induction of adhesionproteins and dramatic regression of malignancy in vitro and in vivo, Mol Cancer Res, 2005, 3(7):365-371.
21. OSHIMA R. G., BARIBAULT H., CAULÍN C., Oncogenic regulation and function of keratins 8 and 18, CancerMetastasis Rev, 1996, 15(4):445-471.
22. WALKER L. C., HARRIS G. C., HOLLOWAY A. J., MCKENZIE G. W., WELLS J. E., ROBINSON B. A., MORRIS C. M., Cytokeratin KRT8/18 expression differentiates distinct subtypes of grade 3 invasive ductal carcinoma of the breast, Cancer Genet Cytogenet, 2007, 178(2):94-103.